GRFS (Grifois, S.A.) Stock Analysis - Insider Trades

Grifois, S.A. (GRFS) is a publicly traded Healthcare sector company. As of May 21, 2026, GRFS trades at $8.20 with a market cap of $5.36B and a P/E ratio of 0.00. GRFS moved +4.46% today. Year to date, GRFS is -12.12%; over the trailing twelve months it is +1.87%. Its 52-week range spans $6.19 to $11.14. Rallies surfaces GRFS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading GRFS stock inside the company?

Rallies tracks GRFS insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

GRFS Key Metrics

Key financial metrics for GRFS
MetricValue
Price$8.20
Market Cap$5.36B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.16%
52-Week High$11.14
52-Week Low$6.19
Volume4
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest GRFS News

GRFS Analyst Consensus

GRFS analyst coverage data. Average price target: $0.00.

Common questions about GRFS

Who is trading GRFS stock inside the company?
Rallies tracks GRFS insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for GRFS?
Yes. Rallies tracks GRFS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GRFS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GRFS. It does not provide personalized investment advice.
GRFS

GRFS